Showing results (1011-1020 of 3,636) with videos related to
Sort By:
Pageof 364
Breast (Edinburgh, Scotland)|May 9, 2008
Severe influence of early pregnancy on newly reconstructed breastNazim GümüşBreast (Edinburgh, Scotland)|May 13, 2008
Postmastectomy locoregional recurrence and distant metastasis in breast carcinoma patientsEmin Yildirim, Ugur BerberogluBreast (Edinburgh, Scotland)|April 11, 2025
Beta blocker use and breast cancer survival by subtypes: A population-based cohort studyOliver William Scott, Sandar Tin Tin, Edoardo BotteriBreast (Edinburgh, Scotland)|April 3, 2025
Computational pathology for breast cancer: Where do we stand for prognostic applications?Grégoire Gessain, Magali Lacroix-TrikiBreast (Edinburgh, Scotland)|April 5, 2025
Clinical characteristics and prognostic factors in patients with breast cancer and leptomeningeal metastases from a large registry of BMBCElena Laakmann, Marcus Schmidt, Kristina Lübbe, et al.Breast (Edinburgh, Scotland)|April 6, 2025
Mapping breast cancer therapy with circulating tumor cells: The expert perspectiveLorenzo Gerratana, Caterina Gianni, Eleonora Nicolò, et al.Breast (Edinburgh, Scotland)|April 26, 2025
"Microsurgical breast reconstruction - A salvage option for failed implant-based breast reconstruction"Amir Khosrow Bigdeli, Jia Wei Tee, Felix Hubertus Vollbach, et al.Breast (Edinburgh, Scotland)|April 16, 2025
Immune-related adverse events among patients with early-stage triple-negative breast cancer treated with pembrolizumab plus chemotherapy: real-world data from the Neo-Real/GBECAM 0123 studyMatheus de Oliveira Andrade, Isabella Gonçalves Gutierres, Monique Celeste Tavares, et al.Breast (Edinburgh, Scotland)|March 30, 2025
Patient perception on risk of recurrence and decision-making in the management of HER2-positive early breast cancer: Insights from the ASKHER2 European surveyMatteo Lambertini, Christian Jackisch, Olivier Trédan, et al.Breast (Edinburgh, Scotland)|March 30, 2025
Comparison of neoadjuvant and adjuvant chemotherapy for operable triple-negative breast cancer before the era of immune checkpoint inhibitors: A retrospective study from the Japanese National Clinical Database-Breast Cancer RegistryTomoe Taji, Hiraku Kumamaru, Yuki Kataoka, et al.Pageof 364